計量生物学
Online ISSN : 2185-6494
Print ISSN : 0918-4430
ISSN-L : 0918-4430
日本における MBDD の現状の問題点と今後の課題
笠井 英史
著者情報
ジャーナル フリー

2011 年 32 巻 Special_Issue_2 号 p. S195-S196

詳細
抄録

Model-Based drug development (MBDD) is not so widely used Japan relative to U. S. A and EU. This is because 1) not so many well educated pharmacometricians with enough skills exist in Japan, 2) necessary databases for MBDD are not well organized in Japan. These two deficiencies lead to the paucity of disease progression model for Japanese patients. Pharmacometricians including pahramacokineticists, biostatisticians, and clinical pharmacologists have to collaborate with each other to solve these problems and contribute to the public health of Japan by ensuring development of new effective and safe drug compounds.

著者関連情報
© 2011 日本計量生物学会
前の記事
feedback
Top